NCT01329939View on ClinicalTrials.gov

The Effect of Montelukast on Asthma Control in Overweight/Obese Atopic Asthmatics

NACompletedINTERVENTIONAL

Enrollment

26

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions

AsthmaObesityInflammation

Interventions

DRUG

Montelukast

Age-dependent dose, nightly, 24 weeks

DRUG

Placebo

Age-dependent dose, nightly, 24 weeks

DRUG

Montelukast

Age-dependent dose, nightly, 24 weeks

DRUG

Placebo

Age-dependent dose, nightly, 24 weeks

Trial Locations (1)

11023

North Shore-Long Island Jewish Health System, Division of Allergy/Immunology, Great Neck

Sponsors

Lead Sponsor

Northwell Health

All Listed Sponsors

collaborator

Thrasher Research Fund

OTHER

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

New York State Department of Health

OTHER_GOV

lead

Northwell Health

OTHER